Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations (Unaudited)

v3.10.0.1
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Operating costs and expenses:        
Research and development $ 1,871,242 $ 774,476 $ 2,720,925 $ 1,206,630
Patent costs 48,263 50,661 111,351 128,363
General and administrative 1,686,903 1,144,220 2,812,794 2,315,545
Total operating costs and expenses 3,606,408 1,969,357 5,645,070 3,650,538
Operating loss (3,606,408) (1,969,357) (5,645,070) (3,650,538)
Other income:        
Interest income 21,756 6,333 47,728 14,279
Total other income 21,756 6,333 47,728 14,279
Net loss $ (3,584,652) $ (1,963,024) $ (5,597,342) $ (3,636,259)
Net loss per common share - basic and diluted $ (0.71) $ (1.41) $ (1.12) $ (2.84)
Weighted average common shares outstanding - basic and diluted 5,064,805 1,395,330 5,005,116 1,278,625